New Capital Management’s Pfizer PFE Stock Holding History

New Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$109K	Hold	3,002	–	–	0.1%	48
2020 Q4	$111K	Sell	3,002 -162	-5%	-$5.94K	0.06%	49
2020 Q3	$110K	Hold	3,164	–	–	0.12%	42
2020 Q2	$98K	Buy	3,164 +3,162	+158,100%	+$107K	0.13%	38
2020 Q1	$0	Hold	2	–	–	﹤0.01%	130
2019 Q4	$0	Hold	2	–	–	﹤0.01%	135
2019 Q3	$0	Hold	2	–	–	﹤0.01%	134
2019 Q2	$0	Hold	2	–	–	﹤0.01%	133
2019 Q1	$0	Sell	2 -757	-100%	-$30.3K	﹤0.01%	135
2018 Q4	$31K	Sell	759 -138	-15%	-$5.73K	0.06%	66
2018 Q3	$38K	Buy	897 +152	+20%	+$5.85K	0.06%	70
2018 Q2	$26K	Buy	745 +7	+0.9%	+$239	0.05%	86
2018 Q1	$25K	Buy	+738	New	+$25.4K	0.06%	92

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New Capital Management's PFE Position: Q1 2021 in Review

New Capital Management held its Pfizer (PFE) position steady in Q1 2021 at 3,002 shares worth $109K. The position accounts for 0.1% of the portfolio, ranked #48.

New Capital Management first reported a position in PFE in Q1 2018 and has held it in 13 quarters since. The position peaked at $111K in Q4 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

New Capital Management held 3,002 shares of Pfizer worth $109K as of Q1 2021.
New Capital Management left its Pfizer share count unchanged in Q1 2021.
Pfizer made up 0.1% of New Capital Management's portfolio in Q1 2021, its #48 holding.
New Capital Management first reported a position in Pfizer in Q1 2018 and has held it in 13 quarters since.
New Capital Management's Pfizer position peaked at $111K in Q4 2020.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on New Capital Management's 13F filing for Q1 2021, filed 15 Apr 2021.